Level A evidence. The highest rating any clinical intervention can receive. And yet three percent of eligible COPD patients in the United States actually complete a pulmonary rehab program. That is not a knowledge failure. It is a system failure — and respiratory therapists are the most positioned profession to close it.
The seven key components of an effective COPD pulmonary rehab program: exercise training, education, nutritional assessment, psychosocial support, outcome measurement, exacerbation action plans, and long-term maintenance. Most programs deliver exercise training and some education and call it complete. The psychosocial, nutritional, and maintenance components that produce durable outcomes remain almost universally underdeveloped.
What an evidence-based program actually looks like
Lower and upper extremity endurance training at 60 to 80 percent of peak work capacity, minimum 3 sessions per week, minimum 8 weeks. Programs shorter than 8 weeks show significantly attenuated benefit. Insurance typically covers 36 sessions — approximately 12 weeks at 3x weekly. Use the full authorization every time.
High-flow nasal cannula during pulmonary rehab exercise sessions has emerging evidence for improving exercise tolerance in hypoxemic COPD patients by reducing dynamic hyperinflation and work of breathing. Optimal flow rates: 20 to 40 L/min during moderate exertion is a reasonable starting range.
Benefits decay without ongoing physical activity. Most programs end at 12 weeks with no structured maintenance plan. The RTs who build long-term maintenance pathways produce durable outcomes. Without maintenance, you are treating a chronic disease with an acute intervention.
50% Reduction in COPD hospitalization with comprehensive pulmonary rehab | 12 wks Minimum duration for sustained benefit in most high-quality studies | 3% Of eligible U.S. COPD patients who actually complete pulmonary rehab |
“Three percent. We have level A evidence, insurance coverage, and documented outcomes that match any pharmacological intervention. This is a referral problem, an access problem, and a system design problem. It is also an RT advocacy problem.”
The most common reason eligible COPD patients do not attend pulmonary rehab is that nobody referred them. RTs who identify eligible patients and actively facilitate referrals — making the call, submitting the paperwork, following up — are the single most effective intervention in the referral pipeline. Do not suggest a referral. Facilitate it yourself.
Pediatric respiratory emergencies are different from adult emergencies in ways that textbooks describe but cannot fully prepare you for. The physiology is different. The margin for error is narrower. And the first ten minutes belong to whoever is in the room.
HFNC has largely replaced low-flow oxygen as initial escalation for moderate bronchiolitis. The critical clinical skill is recognizing when HFNC is failing before the sat drops. Worsening retractions, rising respiratory rate despite adequate flows, increasing apnea frequency, and clinical fatigue are the signals. Watch the work of breathing more than the monitor.
For pediatric status asthmaticus not responding to standard bronchodilator therapy, heliox — typically 80/20 or 70/30 helium-oxygen mixture — reduces work of breathing by decreasing gas density and improving laminar flow. Know your facility's heliox delivery system before you need it.
Racemic epinephrine produces rapid improvement through mucosal vasoconstriction. Critical point: symptoms typically return 2 to 3 hours after treatment as the drug effect wanes. Discharge within 2 hours of racemic epinephrine in a child with moderate croup is dangerous regardless of how good they look in the moment.
Rare since Hib vaccination but not gone. The presentation: tripod position, drooling, toxic-appearing child maintaining their airway by compensation. Do not lay this child down. Do not attempt to visualize the airway outside a controlled setting. Move directly to the OR with anesthesia for controlled intubation. Keep the child calm and upright.
Respiratory therapists are among the most systematically underpaid clinical professionals in the hospital relative to their scope and the acuity of patients they manage. A significant portion of that gap is self-inflicted: RTs consistently fail to negotiate, fail to leverage competing offers, and fail to document clinical value in ways that support salary arguments.
The BLS median for respiratory therapists in 2025 was $77,240. The range runs from $54,000 at the 10th percentile to over $105,000 at the 90th. The difference between the median and the 90th percentile is not primarily experience — it is specialty credential, market, and negotiation.
The conversation about your salary should start with your research, not the employer's offer. BLS regional data, Glassdoor, LinkedIn Salary, and direct conversations with colleagues in similar roles. Know the range for your credentials in your specific market before any salary discussion.
Nothing moves a salary conversation like a documented competing offer. This requires actually applying, actually interviewing, and actually receiving written offers — even if you prefer your current employer. A verbal statement that you have other options is easily dismissed. A written offer letter is not.
The strongest salary argument combines market data with facility-specific outcome documentation. If your weaning protocol cut ventilator days, if your HFNC management prevented intubations — in documented numbers with dates — you have a business case. Build this file continuously. Not the week before your annual review.
$77K BLS median RT salary — $28K below the 90th percentile | $15K Average salary premium for specialty-credentialed RTs at major centers | 68% Of RTs who report never formally negotiating their starting salary |
“The money is not going to find you. The hospital will pay what you accepted last time unless you make a specific, documented, evidence-supported case for something different. That case is your responsibility to build.”
Next: Wearable technology for respiratory monitoring — what the evidence actually says, not what the marketing says.
Soon: Salary negotiation part two — what to do when they say no.
On deck: Ionized magnesium in critical care — the lab value most RTs never check.
Staying at the vent,
15 years across academic medical centers & community hospitals
